MA23794A1 - Utilisation de phenylcyclohexylcarboxamides - Google Patents

Utilisation de phenylcyclohexylcarboxamides

Info

Publication number
MA23794A1
MA23794A1 MA24149A MA24149A MA23794A1 MA 23794 A1 MA23794 A1 MA 23794A1 MA 24149 A MA24149 A MA 24149A MA 24149 A MA24149 A MA 24149A MA 23794 A1 MA23794 A1 MA 23794A1
Authority
MA
Morocco
Prior art keywords
phenylcyclohexylcarboxamides
Prior art date
Application number
MA24149A
Other languages
English (en)
Inventor
Muller-Gliemann Matthias
Beuck Martin
Lohmer Stefan
Yalkinoglu Ozkan
Denzer Dirk
Muller Ulrich
Zaiss Siegfried
Domdey-Bette Anke
Wohlfeil Stefan
Elting James
Gerdes Christoph
Grutzmann Rudi
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MA23794A1 publication Critical patent/MA23794A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA24149A 1995-02-01 1996-02-01 Utilisation de phenylcyclohexylcarboxamides MA23794A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19503160A DE19503160A1 (de) 1995-02-01 1995-02-01 Verwendung von Phenylcyclohexylcarbonsäureamiden

Publications (1)

Publication Number Publication Date
MA23794A1 true MA23794A1 (fr) 1996-10-01

Family

ID=7752849

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24149A MA23794A1 (fr) 1995-02-01 1996-02-01 Utilisation de phenylcyclohexylcarboxamides

Country Status (31)

Country Link
US (1) US5935983A (fr)
EP (1) EP0725064A1 (fr)
JP (1) JPH08253453A (fr)
KR (1) KR960031442A (fr)
CN (1) CN1137380A (fr)
AR (1) AR002272A1 (fr)
AU (1) AU710235B2 (fr)
BG (2) BG103820A (fr)
CA (1) CA2168317A1 (fr)
CZ (1) CZ29196A3 (fr)
DE (1) DE19503160A1 (fr)
DZ (1) DZ1986A1 (fr)
EE (1) EE9600023A (fr)
FI (1) FI960425A (fr)
HR (1) HRP960017A2 (fr)
HU (1) HUP9600227A3 (fr)
IL (1) IL116931A (fr)
MA (1) MA23794A1 (fr)
NO (1) NO309841B1 (fr)
NZ (1) NZ280905A (fr)
PL (1) PL312546A1 (fr)
RO (1) RO117256B1 (fr)
RU (1) RU2158261C2 (fr)
SG (1) SG42329A1 (fr)
SK (1) SK13796A3 (fr)
SV (1) SV1996000008A (fr)
TN (1) TNSN96016A1 (fr)
TW (1) TW448176B (fr)
UA (1) UA35623C2 (fr)
YU (1) YU5896A (fr)
ZA (1) ZA96725B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911462B2 (en) * 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
DE19924818A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
DE19924819A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren)
ATE369853T1 (de) * 2001-03-12 2007-09-15 Avanir Pharmaceuticals Benzimidazolderivate zur ige-modulierung und zellproliferationshemmung
DE10150310A1 (de) * 2001-10-11 2003-04-24 Bayer Ag Substituierte Piperazincyclohexancarbonsäureamide und ihre Verwendung
US6934951B2 (en) 2002-01-17 2005-08-23 Intel Corporation Parallel processor with functional pipeline providing programming engines by supporting multiple contexts and critical section
TW200304820A (en) * 2002-03-25 2003-10-16 Avanir Pharmaceuticals Use of benzimidazole analogs in the treatment of cell proliferation
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
TWI276631B (en) * 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
JP2007501618A (ja) * 2003-08-08 2007-02-01 アバニール・ファーマシューティカルズ タンパク質輸送の選択的薬理学的阻害、および関連した、ヒト疾患を治療する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4226109A1 (de) * 1992-08-07 1994-02-10 Bayer Ag Verwendung von ASS zur Hemmung von Plaquebildung
DE4304455A1 (de) * 1993-02-15 1994-08-18 Bayer Ag Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
US5358959A (en) * 1993-02-18 1994-10-25 President And Fellows Of Harvard University Methods for treating arteriosclerosis
DE4401893A1 (de) * 1994-01-24 1995-07-27 Bayer Ag Substituierte Arylharnstoffe

Also Published As

Publication number Publication date
TNSN96016A1 (fr) 2005-03-15
SK13796A3 (en) 1996-10-02
HUP9600227A2 (en) 1996-12-30
CA2168317A1 (fr) 1996-08-02
PL312546A1 (en) 1996-08-05
HRP960017A2 (en) 1997-12-31
NO309841B1 (no) 2001-04-09
EP0725064A1 (fr) 1996-08-07
FI960425A0 (fi) 1996-01-30
SV1996000008A (es) 1996-11-04
BG103820A (bg) 2001-09-28
UA35623C2 (uk) 2001-04-16
DZ1986A1 (fr) 2002-10-15
TW448176B (en) 2001-08-01
US5935983A (en) 1999-08-10
SG42329A1 (en) 1997-08-15
AU4224096A (en) 1996-08-08
AR002272A1 (es) 1998-03-11
NO960414L (no) 1996-08-02
DE19503160A1 (de) 1996-08-08
NZ280905A (en) 1996-12-20
NO960414D0 (no) 1996-01-31
BG100326A (bg) 1996-08-30
BG63044B1 (bg) 2001-02-28
KR960031442A (ko) 1996-09-17
IL116931A (en) 2000-06-01
HU9600227D0 (en) 1996-03-28
IL116931A0 (en) 1996-05-14
ZA96725B (en) 1996-08-20
FI960425A (fi) 1996-08-02
YU5896A (sh) 1998-12-23
CN1137380A (zh) 1996-12-11
CZ29196A3 (en) 1996-08-14
JPH08253453A (ja) 1996-10-01
RU2158261C2 (ru) 2000-10-27
RO117256B1 (ro) 2001-12-28
HUP9600227A3 (en) 2000-03-28
AU710235B2 (en) 1999-09-16
EE9600023A (et) 1996-08-15

Similar Documents

Publication Publication Date Title
DE69631647D1 (de) Erfassung von möglichem betrügerischen gebrauch von kommunikation
DE69634533D1 (de) Wegwerfartikel
BR9609682A (pt) Foto-desinfetantes de baixa nuança
DK0825860T3 (da) Præpart
ATA135896A (de) Skibob
MA23794A1 (fr) Utilisation de phenylcyclohexylcarboxamides
DE59608223D1 (de) Konverter
ATE198470T1 (de) Alkenyl-benzoylguanidine
PT839024E (pt) Formulacoes de monensina
IT1276074B1 (it) Rettoscopio monouso
ATE240972T1 (de) Cyclopeptolide
ATA119896A (de) Scheibenmähwerk
FI950718A0 (fi) Alusta
KR970020855U (ko) 가제 고정 안대
UA1112S (uk) Мікро-еом широкого призначення
KR970002630A (ko) 병-직렬 변환기
KR970004268U (ko) 붕대
FI1830U1 (fi) Kaepp foer gaong pao is
KR970010719U (ko) 스케일 변환자
BR9501414A (pt) Conversores
FIU950472U0 (fi) Bandage foer skoetsel av svullnader
SE9504291D0 (sv) Elektro-akustisk omvandlare
BR9605659A (pt) Conjunto de óculos de proteção
FIU950225U0 (fi) Foerandring mullskydd + kruka
FIU950203U0 (fi) Myllskydd + kruka